Similarly, SMG1 has been implicated in DNA damage responses and identified as a tumor suppressor linked to different cancers, stimulating interest in SMG1 as a novel target for drug therapies and a biomarker for cancer prognosis11,28,29. The gene discussed is SMG1; the disease is neoplasm.